Differences in kinetics of donor lymphoid cells in response to G-CSF administration may affect the incidence and severity of acute GvHD in respective HLA-identical sibling recipients

Author： Trzonkowski Piotr   Zaucha Jan   Myśliwska Jolanta   Balon Joanna   Szmit Ewa   Hałaburda Kazimierz   Bieniaszewska Maria   Młotkowska Monika   Hellmann Andrzej   Myśliwski Andrzej  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.21, Iss.1, 2004-03, pp. : 81-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients

By Rajan Suja   Stearns Sally   Lyman Gary   Carpenter William  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 255-266

Springer Publishing Company

Access to resources Recommend Favorite

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

By Frasci Giuseppe   Comella Pasquale   D'Aiuto Giuseppe   Budillon Alfredo   Barbarulo Deborah   Thomas Renato   Capasso Immacolata   Casaretti Rossana   Daponte Antonio   Caponigro Francesco   Gravina Adriano   Maiorino Luigi   Caratení Giacomo   Gentile Alfonso   Comella Giuseppe  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 13-26

Springer Publishing Company

Access to resources Recommend Favorite

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF

By Wenzel Catharina   Bartsch Rupert   Hussian Dagmar   Pluschnig Ursula   Altorjai Gabriela   Zielinski Christoph   Lang Alois   Haid Anton   Jakesz Raimund   Gnant Michael   Steger Guenther  

Breast Cancer Research and Treatment, Vol. 104, Iss. 1, 2007-07 ,pp. : 109-114

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells

By Weiss Lola   Or Reuven   Slavin Shimon   Naparstek Ella   Reich Shoshana   Abdul-Hai Ali  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 358-362

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

By Frasci G.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 87-97

Springer Publishing Company

Access to resources Recommend Favorite